Skip to main content
HeartCited

Vitamin K2 pour Arterial Stiffness

B

Rotterdam Heart Study: 57% lower CV mortality with highest K2 intake. KNAPEN RCT: MK-7 (180 mcg/day, 3 years) significantly improved arterial stiffness in postmenopausal women.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dvitamin\u002Dk2\u0026condition\u003Darterial\u002Dstiffness'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
En conclusion

            
            
Rotterdam Heart Study: 57% lower CV mortality with highest K2 intake. KNAPEN RCT: MK-7 (180 mcg/day, 3 years) significantly improved arterial stiffness in postmenopausal women.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
5

        
Études

    

    

        
1200

        
Participants

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
Note

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
Posologies couramment utilisées

                

                    
                    

                        
general:

                        
90-120 mcg/day (MK-7 preferred)

                    

                    
                    

                        
cardiovascularsupport:

                        
180-360 mcg/day MK-7

                    

                    
                

                
                

                    Limite supérieure : Not established (no known toxicity for K2 at supplemental doses)
                

                
            

            

            

            
            

                Moment optimal de prise : With meals containing fat; can combine with vitamin D supplement
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
Effets indésirables signalés

                    
    
                        
                        
  • 
                            ⚠
                            Generally very well-tolerated
                        
    • 
                        
                        
  • 
                            ⚠
                            Does not affect blood clotting (INR) at supplemental doses, unlike K1
                        
    • 
                        
                    

                

                

                
                

                    
Interactions connues

                    
    
                        
                        
  • 
                            ●
                            Warfarin (patients on warfarin should consult physician before K2 supplementation)
                        
    • 
                        
                        
  • 
                            ●
                            Vitamin D (synergistic — D increases MGP production, K2 activates it)
                        
    • 
                        
                    

                

                

                
                

                    

                        Apport maximal tolérable : Not established (no known toxicity for K2 at supplemental doses)
                    

                

                
            

            

                Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Vitamin K2 help with Arterial Stiffness?
            
        
        

            Based on 5 studies with 1,200 participants, there is moderate evidence from clinical studies that Vitamin K2 may support Arterial Stiffness management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Vitamin K2 should I take for Arterial Stiffness?
            
        
        

            Studies have used various dosages. A commonly studied range is 90-120 mcg/day (MK-7 preferred). Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Vitamin K2?
            
        
        

            Reported side effects may include Generally very well-tolerated, Does not affect blood clotting (INR) at supplemental doses, unlike K1. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Vitamin K2 and Arterial Stiffness?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 1,200 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                

                    
Autres ingrédients pour Arterial Stiffness

                    

                        
                        
                            NMN (Nicotinamide Mononucleotide)
                            C

                        
                        
                    

                

                

                
            

        

        

    


    
    












    

        Avertissement FDA:
        Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.